ATE493439T1 - Monoklonale ykl-40-antikörper - Google Patents

Monoklonale ykl-40-antikörper

Info

Publication number
ATE493439T1
ATE493439T1 AT06706064T AT06706064T ATE493439T1 AT E493439 T1 ATE493439 T1 AT E493439T1 AT 06706064 T AT06706064 T AT 06706064T AT 06706064 T AT06706064 T AT 06706064T AT E493439 T1 ATE493439 T1 AT E493439T1
Authority
AT
Austria
Prior art keywords
ykl
antibodies
pharmaceutical compositions
relates
monoclonal
Prior art date
Application number
AT06706064T
Other languages
English (en)
Inventor
Richard Bonnichsen
Paul Price
Original Assignee
Bio Y As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36385676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE493439(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Y As filed Critical Bio Y As
Application granted granted Critical
Publication of ATE493439T1 publication Critical patent/ATE493439T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06706064T 2005-02-28 2006-02-16 Monoklonale ykl-40-antikörper ATE493439T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500300 2005-02-28
PCT/DK2006/000093 WO2006089549A1 (en) 2005-02-28 2006-02-16 Ykl-40 monoclonal antibodies

Publications (1)

Publication Number Publication Date
ATE493439T1 true ATE493439T1 (de) 2011-01-15

Family

ID=36385676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06706064T ATE493439T1 (de) 2005-02-28 2006-02-16 Monoklonale ykl-40-antikörper

Country Status (10)

Country Link
US (2) US8053563B2 (de)
EP (1) EP1856153B1 (de)
JP (1) JP2008531608A (de)
AT (1) ATE493439T1 (de)
AU (1) AU2006218237B2 (de)
CA (1) CA2599439A1 (de)
DE (1) DE602006019205D1 (de)
ES (1) ES2358917T3 (de)
PL (1) PL1856153T3 (de)
WO (1) WO2006089549A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229770B1 (en) 1998-10-01 2007-06-12 The Regents Of The University Of California YKL-40 as a marker and prognostic indicator for cancers
AU2002319680B2 (en) 2001-07-24 2008-04-10 Yale University Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
EP1856153B1 (de) * 2005-02-28 2010-12-29 Bio-Y A/S Monoklonale ykl-40-antikörper
FR2908654B1 (fr) * 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
US8697384B2 (en) 2008-01-23 2014-04-15 Herlev Hospital YKL-40 as a general marker for non-specific disease
CN101587125B (zh) * 2008-05-21 2013-07-24 林标扬 高表达癌症标记物和低表达组织器官标记物组合试剂盒
NZ592241A (en) 2008-09-15 2012-11-30 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
CN104335045B (zh) * 2012-02-27 2017-02-22 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
CN105092855B (zh) * 2014-05-23 2017-10-03 杭州普望生物技术有限公司 一种用于肝纤维化和肝硬化检测的试剂盒
US10473671B2 (en) 2014-12-18 2019-11-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3565596A4 (de) 2017-01-05 2020-12-16 Brown University Verfahren und zusammensetzungen in verbindung mit anti-chi3l1-antikörperreagenzien
US10766968B2 (en) 2017-08-23 2020-09-08 Brown University Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer
WO2019060675A1 (en) * 2017-09-21 2019-03-28 Yale University ANTI-YKL40 ANTIBODIES AND METHODS OF USE
KR102083478B1 (ko) 2017-12-28 2020-04-28 한양대학교 산학협력단 Chi3l1 억제제를 유효성분으로 하는 암의 폐 전이 예방 또는 치료용 약학 조성물
WO2019217450A1 (en) * 2018-05-08 2019-11-14 Rhode Island Hospital Anti-chi3l1 antibodies for the detection and/or treatment of nonalcoholic fattly liver disease/nonalcoholic steatohepatitis and subsequent complications
WO2020097347A1 (en) * 2018-11-07 2020-05-14 Brown University Methods and compositions relating to anti-chi3l1 antibody reagents for the treatment of fibrosis
TWI733274B (zh) 2018-12-13 2021-07-11 財團法人生物技術開發中心 抗人類csf-1r抗體及其用途
KR102142499B1 (ko) * 2019-09-11 2020-08-10 재단법인 오송첨단의료산업진흥재단 Ykl-40 표적 인간 단일클론항체
US11498978B2 (en) 2020-05-05 2022-11-15 Bio-Y A/S YKL-40 antibody
KR20230011064A (ko) * 2021-07-13 2023-01-20 충북대학교 산학협력단 Chi3L1에 특이적인 인간화 단일클론항체를 포함하는 대식세포의 M2 분극화 억제 및 암의 치료용 조성물
EP4702056A1 (de) * 2023-04-28 2026-03-04 Bio-Y A/S Antikörper gegen ykl-40 und ihre verwendungen
US12428495B2 (en) * 2023-04-28 2025-09-30 Bio-Y A/S Antibodies against YKL-40 and uses thereof
WO2025048518A1 (ko) * 2023-08-31 2025-03-06 충북대학교 산학협력단 Ｃｈｉ３ｌ１에 특이적인 인간 단일클론항체를 포함하는 류마티스 관절염 예방 또는 치료용 조성물

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2624972A (en) * 1947-05-12 1953-01-13 Leo R Burg Ice fishing rig
US3016648A (en) * 1958-06-25 1962-01-16 Robert D Ingersoll Mechanical fishing device
US3238658A (en) * 1965-06-28 1966-03-08 Eaumett A Hall Automatic fish catcher
US3474561A (en) * 1967-10-19 1969-10-28 Alfred R Mcconkey Ice fishing rig with self-contained automatic catcher
US3686785A (en) * 1971-02-26 1972-08-29 John L Dixon Fishing device
US4021958A (en) * 1975-10-06 1977-05-10 Snodie William R Ice fishing tip-up
US4083139A (en) * 1976-10-22 1978-04-11 Schwend Gerald M Ice fishing apparatus
US4085536A (en) * 1976-12-13 1978-04-25 Wood Jr Everett J Automatic fishing device
US4321767A (en) * 1979-07-06 1982-03-30 Hodshire Vincent B Ice fishing apparatus
US4373287A (en) * 1980-10-03 1983-02-15 Grahl Paul F Fishing tip-up
US4354324A (en) * 1980-12-08 1982-10-19 Eblen James H Fishing rod holding device
US4393615A (en) * 1981-11-30 1983-07-19 Hodshire Vincent B Fishing apparatus
US4416079A (en) * 1982-06-07 1983-11-22 Hodshire Vincent B Fishing apparatus
US4471553A (en) * 1982-06-30 1984-09-18 Copeland Darrell L Spring loaded fishing rod holder
US4461113A (en) * 1982-07-30 1984-07-24 G. Gene Henthorn Automatic fishhook setting apparatus
US4434573A (en) * 1982-09-16 1984-03-06 Hodshire Vincent B Fishing apparatus
CA1268040A (en) * 1986-07-04 1990-04-24 Warren Cooper Semi-automatic fishing apparatus
US4837965A (en) * 1988-04-14 1989-06-13 True Donovan B Ice fishing tip-up
US4941278A (en) * 1989-12-06 1990-07-17 Steve Verkuil Vertical fishing trip-up
US5050333A (en) * 1990-11-29 1991-09-24 Joe Debreczeni Fishing rig
US5274944A (en) * 1990-12-31 1994-01-04 Laessig Kenneth R Tip-up
US7229770B1 (en) 1998-10-01 2007-06-12 The Regents Of The University Of California YKL-40 as a marker and prognostic indicator for cancers
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5491923A (en) * 1994-01-31 1996-02-20 Zingrone; Thomas G. Fishing pole holder
CN1068309C (zh) * 1994-07-04 2001-07-11 旭化成工业株式会社 氨基脲衍生物及含其的涂料组合物
US5570534A (en) * 1995-06-06 1996-11-05 Michael R. Bowen Fishing rod jigger and automatic hook setting device
IL120561A0 (en) * 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
US5911569A (en) * 1998-02-06 1999-06-15 Isakson; Eric Ice fishing hole cover and indicator
US5992080A (en) * 1999-03-29 1999-11-30 Allen; Garth M. Fishing trap
US6772551B1 (en) * 1999-05-25 2004-08-10 Richard D. J. Bielinski, Sr. Hook set and rod holder
US20050214297A1 (en) * 2004-02-25 2005-09-29 Medimmune, Inc. Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts
EP1856153B1 (de) * 2005-02-28 2010-12-29 Bio-Y A/S Monoklonale ykl-40-antikörper

Also Published As

Publication number Publication date
CA2599439A1 (en) 2006-08-31
AU2006218237A1 (en) 2006-08-31
US20120149882A1 (en) 2012-06-14
US8673301B2 (en) 2014-03-18
ES2358917T3 (es) 2011-05-16
EP1856153B1 (de) 2010-12-29
DE602006019205D1 (de) 2011-02-10
PL1856153T3 (pl) 2011-06-30
EP1856153A1 (de) 2007-11-21
US8053563B2 (en) 2011-11-08
WO2006089549A1 (en) 2006-08-31
US20090175870A1 (en) 2009-07-09
AU2006218237B2 (en) 2012-01-12
JP2008531608A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
ATE493439T1 (de) Monoklonale ykl-40-antikörper
BRPI0613382A8 (pt) anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor
MA29595B1 (fr) Anticorps anti-cd40 humanises et procedes d'utilisation
NZ592432A (en) Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1)
GB201020995D0 (en) Biological materials and uses thereof
AU2010220421A8 (en) Antibodies against a proliferating inducing ligand (APRIL)
TN2012000555A1 (en) Antibodies to human gdf8
DK1836225T3 (da) Kir-bindingagenser og fremgangsmåde til anvendelse deraf
NO20084650L (no) Modifiserte humaniserte anti-interleukin-18 antistoffer
EP2331136A4 (de) Frizzled-bindende stoffe und ihre verwendungen
UA107490C2 (uk) TNF-α-ЗВ'ЯЗУВАЛЬНИЙ БІЛОК
BRPI0812691B8 (pt) Anticorpos anti-cd79b, imunoconjugado, composições farmacêuticas, método de inibição do crescimento de uma célula que expressa cd79b, método de determinar a presença de cd79b e usos de um imunoconjugado
CL2007003622A1 (es) Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
UA102867C2 (uk) Антитіла до cxcr4 та їх застосування у лікуванні раку
BR122017025062B8 (pt) anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento
MX2018005512A (es) Agentes de union de esclerostina.
EA201100779A1 (ru) Композиции антител к cxcr1 и способы их применения
EA200702053A1 (ru) Антитела против cd38 для лечения множественной миеломы
MX2012004084A (es) Anticuerpos siglec-15 para tratar enfermedad relacionada con perdida osea.
DK1896507T3 (da) Anti-CD71-monoklonale antistoffer og anvendelser deraf til behandling af maligne tumorceller
CR9969A (es) Anticuerpos anti-globulomero ab, porciones de union a antigeno de estos, hibridomas correspondientes, acidos nucleicos, vectores, celulas huesped, metodos para producir dichos anticuerpos, composiciones que comprenden dichos anticuerpos
TR201820837T4 (tr) Natalizumab antikor formülasyonları.
DE602006019565D1 (de) Monoklonaler anti-cd20-antikörper
NZ592830A (en) Process for the modulation of the antagonistic activity of a monoclonal antibody
EA201070636A1 (ru) Ингибирование рецептора белка, стимулирующего макрофаги (ron), и способы его лечения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties